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Abstract 
Background: Pyomyositis is typically caused by Staphylococcus aureus, and is rare in temperate climates, 
although its prevalence has been recently increasing. This infection often involves the thigh, and is associated with 
immunodeficiency.
Case presentation: We report the case of a healthy 20-year-old Japanese woman who experienced a fever and 
continuous pain for several days. She was admitted to our hospital and was diagnosed with pyomyositis after we 
discovered an abscess between the muscles of her dorsal distal left thigh using computed tomography. This is a rare 
case of thigh pyomyositis, as it was caused by group A streptococcus and occurred in an immunocompetent adult 
from a temperate climate.
Conclusions: Our review of the literature revealed that group A streptococcus pyomyositis typically occurs in 
temperate climates, among young adults without any underlying disease, and is associated with a poorer prognosis, 
compared to general pyomyositis. We suggest that pyomyositis should be considered when immunocompetent 
adults present with apparently idiopathic inflammatory muscle lesions.
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Background
Pyomyositis is a bacterial infection of the skeletal muscle 
that is most commonly caused by Staphylococcus aureus 
(S. aureus; 90% of tropical cases and 75% of temper-
ate cases) [1], although it is relatively rare in temperate 
climates. Another 1–5% of cases involve group A strep-
tococcus, and other rare cases may involve streptococ-
cus (groups B, C, and G), pneumococcus, Neisseria spp., 
Haemophilus spp., Aeromonas spp., Serratia spp., Yers-
inia spp., Pseudomonas spp., Klebsiella spp., and Escheri-
chia spp. [1]. The development of pyomyositis is typically 
associated with immune-related conditions (e.g., diabetes 
mellitus, the use of corticosteroids, human immunodefi-
ciency virus (HIV) infection, acquired immune deficiency 
syndrome (AIDS), and malignancies), and most com-
monly affects the muscles of the lower extremities (i.e., 
the thighs and calves) [2]. Among immunocompetent 
patients, pyomyositis is typically accompanied by a his-
tory of a traffic accident [3] or vigorous exercise [4]. Fur-
thermore, pyomyositis caused by group A streptococcus 
(GAS) is a known complication of chicken pox among 
children [5]. Therefore, we report a case of apparently idi-
opathic thigh pyomyositis that was caused by GAS in an 
immunocompetent adult.
Case presentation
A 20-year-old Japanese woman was working in a restau-
rant and experienced discomfort in her left thigh on the 
seventh day before her hospital admission. On the next 
day, she felt pain in the same area while walking, and 
subsequently consulted a physician, who prescribed an 
antiphlogistic sedative patch on the fifth day before her 
admission. On the third day before her admission, she 
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developed a fever (38  °C) and subsequently consulted 
another physician, who prescribed an antipyretic drug. 
However, she continued to experience fever and pain in 
her left thigh flexor during rest. Therefore, she consulted 
another physician and was admitted to our hospital, 
where she was prescribed a single dose of acetaminophen 
(400 mg). She did not have a history of domestic or over-
seas travel, participation in outdoor activities, or trauma.
Upon admission, she had a blood pressure of 
110/63  mmHg, a pulse of 107 beats/min, a respiratory 
rate of 16 breaths/min, and a temperature of 38.9 °C. Her 
left thigh flexor appeared slightly red, with mild swell-
ing, warmth, and pain. However, her head, lungs, heart, 
abdomen, and back did not exhibit redness or swelling. 
Her white blood cell count was 12,100 cells/mm3, her 
hemoglobin level was 10.8 g/dL, and her C-reactive pro-
tein level was 24.11 mg/dL. Her liver and renal functions 
were normal, and the HIV antibody/p24 antigen test 
(fourth generation) provided negative results. However, 
enhanced computed tomography (CT) revealed fluid 
between the dorsal distal muscles of her left thigh and an 
enhanced margin of fluid (Fig. 1), which we diagnosed as 
an abscess. There were no other abscess-like formations 
outside of her lower extremities.
An incision was made in her left thigh on the day of 
admission, the abscess was continuously drained, and 
we treated her using ampicillin/sulbactam (four doses 
per day, up to 12 g daily). Two sets of blood cultures pro-
vided negative results; however, a culture of a fasciotomy 
specimen from the abscess revealed positive results for 
GAS. Definitive identification of the GAS isolate was per-
formed using the rapid streptococcus test (Rapid ID32 
STREP; bioMerieux SA, Marcy l’Etoile, France). There-
fore, we changed the patient’s treatment to penicillin G 
(24 million units per day via continuous infusion) on day 
5. However, drug eruption in response to the penicillin 
G was suspected on day 12, and we changed the antibi-
otic to clindamycin on day 13 (2700  mg in three doses 
per day). We stopped the continuous drainage on day 15, 
and switched the treatment to oral clindamycin on day 16 
(600 mg three times per day). The patient was discharged 
after 17 days in the hospital, and her antibiotic treatment 
lasted 4 weeks. We did not observe any side effects that 
were related to the clindamycin treatment. The patient 
has remained in good health during the 1-year follow-up 
after her discharge from the hospital.
Conclusions
We encountered a rare and apparently idiopathic case 
of non-tropical pyomyositis that was caused by GAS in 
a healthy young Japanese woman. In this context, pyo-
myositis is rare in temperate climates, although it has 
Fig. 1 Enhanced computed tomography reveals fluid between the dorsal distal muscles of the left thigh and an enhanced margin of fluid (white 
arrows)
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recently become more frequent in these climates [6]. The 
clinical features of temperate and tropical cases of pyo-
myositis are summarized in Table 1.
The clinical features of the reported GAS pyomyosi-
tis cases are summarized in Table  2 [5, 9–27]. Many 
of these cases occurred in temperate climates (20/24, 
83.3%), and most patients were children or young 
adults, with relatively few middle-aged patients (mean 
age, 30.3 ± 21.0 years). However, the 20 cases of GAS 
pyomyositis from temperate climates exhibited a mean 
age of 31.5  ±  22.3  years, and only included six pedi-
atric cases, which differs from the general charac-
teristics of tropical pyomyositis. Furthermore, GAS 
infection is a known complication of chicken pox in 
children [5], although only 1 of the 6 pediatric cases 
was GAS-positive. Although pyomyositis typically 
occurs in the lower extremities (9/24, 37.5%) [5, 9–27], 
other muscle groups can be involved, such as the iliac 
[10], psoas [11, 17], iliopsoas [11], trunk [5], neck [13, 
18, 26, 27], and upper extremity muscles [14, 16, 19, 
22, 25]. Involvement of multiple muscle groups is also 
common (9/24, 37.5%). Interestingly, cases of GAS 
pyomyositis typically resemble general pyomyositis 
[28], although many cases are apparently idiopathic, 
which is more similar to cases of tropical pyomyosi-
tis [2]. Positive blood cultures were observed in 9 of 
the 24 temperate cases (37.5%), approximately 60% 
(14/24) of the cases involved surgical drainage (which 
was performed via fasciotomy), and no cases required 
amputation. The mortality rate was 12.5% (3/24), and 
four cases involved an intensive care unit stay, which 
would indicate that the temperate cases were more 
severe than general pyomyositis [6, 9]. Thus, GAS pyo-
myositis typically occurs in temperate climates, among 
young adults without underlying disease, and is asso-
ciated with a poorer prognosis, compared to general 
pyomyositis. The reasons for these observations are 
unclear, although Mandell, Douglas, and Bennett’s 
Principles and Practice of Infectious Diseases [29] indi-
cates that most GAS pyomyositis cases occur sponta-
neously or after blunt non-penetrating trauma, and the 
bacteria are most likely hematogenously translocated 
from the throat to the deep tissues. In addition, GAS 
is the most common cause of bacterial pharyngitis 
among children and young adults [29]. Furthermore, 
children and young adults are often highly active and 
may readily experience blunt non-penetrating trauma. 
Therefore, we hypothesize that the clinical features of 
GAS pyomyositis may be related to these factors.
It is difficult to diagnose pyomyositis, as there are no 
specific symptoms, and the only early symptoms are 
minor pain and swelling. Therefore, patients are often 
slow to consult with a physician, and the diagnosis is 
often delayed by 2–3  weeks [1]. When the diagnosis is 
delayed, death can be caused by septic complications, 
which include toxic shock syndrome [9]. In the present 
case, the patient exhibited minor swelling, redness, and 
warmth in her thigh, and we were able to rapidly diag-
nose pyomyositis based on our physical findings and the 
CT results. This rapid diagnosis allowed us to quickly 
start antibiotic treatment and drainage, which are both 
critical for treating pyomyositis (except during the early 
stage) [30].
We reported a rare case of apparently idiopathic thigh 
pyomyositis that was caused by GAS in an immuno-
competent adult. Furthermore, our review of the litera-
ture revealed that GAS pyomyositis typically occurs in 
temperate climates, among young adults without any 
underlying disease, and is associated with a poorer prog-
nosis, compared to general pyomyositis. Therefore, pyo-
myositis should be considered when a patient presents 
with inflammatory lesions in the thigh or other common 
Table 1 The general clinical features of pyomyositis in temperate and tropical cases
Temperate cases Tropical cases
Ages [1, 2, 7] Adults (elderly) Children (2–5 years) and adults (35–40 years)
Underlying conditions [2, 8] Immunocompromised or serious underlying conditions,  
such as HIV infection, diabetes mellitus, leukemia, chronic  
renal failure, asplenia, scleroderma, rheumatoid arthritis, Felty’s 
syndrome, chemotherapy, or immunosuppressive treatment
Healthy
Microbiology (S. aureus) [1] (%) 60–75 >90
Positive blood cultures [1] (%) 20–30 5–10
Mortality [6, 9] (%) 6.0–9.4 0.5–2.0
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pyomyositis sites, even when the patient is not immuno-
compromised and does not exhibit the standard charac-
teristics of pyomyositis.
Abbreviations
GAS: group A streptococcus; CT: computed tomography; HIV: human immu-
nodeficiency virus; AIDS: acquired immune deficiency syndrome.
Authors’ contributions
KM: Managing the patient, writing the manuscript, and revising the manu-
script. TK: Writing, correcting, and revising the manuscript. AK: Management 
the patient and revising the manuscript. Masami Matsumura: Revising the 
manuscript and the figure. All authors read and approved the final manuscript.
Author details
1 Division of General Internal Medicine, Jichi Medical University Hospital, Shi-
motsuke, Japan. 2 Department of General Medicine, Toyooka Public Hospital, 
Toyooka, Japan. 3 Division of Community Medicine and Career Development, 
Kobe University Graduate School of Medicine, 2-1-5 Arata-cho, Hyogo-ku, 




The authors declare that they have no competing interests.
Availability of data and materials
All data supporting our findings are contained within the manuscript.
Consent for publication
Written informed consent was obtained from the patient for publication of 
this Case Report and any accompanying images.
Funding
No funding was received for this report.
Received: 30 June 2016   Accepted: 16 December 2016
References
 1. Chauhan S, Jain S, Varma S, Chauhan SS. Tropical pyomyositis (myositis 
tropicans): current perspective. Postgrad Med J. 2004;80:267–70.
 2. Lopez-Rodriguez R, Campos-Franco J, Mallo-Gonzalez N, Alende-Sixto 
MR, Gonzalez-Quintela A. Sternocleidomastoid and pectoralis major pyo-
myositis in an immunocompetent patient. Orthopedics. 2008;31:1146.
 3. Diamandakis V, Grose C. Bad consequences of bicycle accidents. Pyomy-
ositis. Pediatr Infect Dis J. 1994;13:422–5.
 4. Jayoussi R, Bialik V, Eyal A, Shehadeh N, Etzioni A. Pyomyositis caused by 
vigorous exercise in a boy. Acta Paediatr. 1995;84:226–7.
 5. Cherry C, Wiggins K, Mijch A, Ostergaard L. Non-tropical thoraco-abdom-
inal pyomyositis caused by group A streptococcus in an immunocompe-
tent adult. Scand J Infect Dis. 2001;33:854–6.
 6. Drosos G. Pyomyositis. A literature review. Acta Orthop Belg. 
2005;71:9–16.
 7. Bickels J, Ben-Sira L, Kessler A, Wientroub S. Primary pyomyositis. J Bone 
Joint Surg Am. 2002;84A:2277–86.
 8. Christin L, Sarosi GA. Pyomyositis in North America: case reports and 
review. Clin Infect Dis. 1992;15:668–77.
 9. Ali I, Rashdan I. Pyomyositis: a case report and literature review. Hosp 
Physician. 1999;35:39–42.
 10. Ceulemans R, Clybouw A, De Schepper AM. Rapidly progressive pyomy-
ositis. J Belge Radiol. 1995;78:226.
 11. Kern L, Rassbach C, Ottolini M. Streptococcal pyomyositis of the psoas: 
case reports and review. Pediatr Emerg Care. 2006;22:250–3.
 12. Cowan MR, Primm PA, Scott SM, Abramo TJ, Wiebe RA. Serious group 
A beta-hemolytic streptococcal infections complicating varicella. Ann 
Emerg Med. 1994;23:818–22.
 13. Pannaraj PS, Hulten KG, Gonzalez BE, Mason EO Jr, Kaplan SL. Infective 
pyomyositis and myositis in children in the era of community-acquired, 
methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 
2006;43:953–60.
 14. Brown JD, Wheeler B. Pyomyositis. Report of 18 cases in Hawaii. Arch 
Intern Med. 1984;144:1749–51.
 15. Farrag N, Kavanagh TG, Chin T. Pyomyositis—an under-reported disease 
in temperate climates. J Infect. 1988;17:259–63.
 16. Feigenberg T, Sela HY, Applbaum YH, Mankuta D. Puerperal widespread 
pyomyositis after group A streptococcal toxic shock syndrome. Isr Med 
Assoc J. 2008;10:483–4.
 17. Skoutelis A, Andonopoulos A, Panagiotopoulos E, Bassaris H. Non-tropical 
pyomyositis in adults: report of four cases and literature review. Eur J Clin 
Microbiol Infect Dis. 1993;12:769–72.
 18. Gosnell EJ, Anwar B, Varadarajan V, Freeman S. Sternocleidomastoid 
pyomyositis. Eur Ann Otorhinolaryngol Head Neck Dis. 2016;133:273–5.
 19. Andrew JG, Czyz WM. Pyomyositis presenting as septic arthritis. A report 
of 2 cases. Acta Orthop Scand. 1988;59:587–8.
 20. Adams EM, Gudmundsson S, Yocum DE, Haselby RC, Craig WA, Sund-
strom WR. Streptococcal myositis. Arch Intern Med. 1985;145:1020–3.
 21. Lawrentschuk N, Falkenberg MP, Pirpiris M. Primary bacterial pyomyositis 
associated with septic arthritis caused by Streptococcus pyogenes: a case 
report. Am J Orthop (Belle Mead NJ). 2003;32:148–50.
 22. Jorup-Ronstrom C, Hofling M, Lundberg C, Holm S. Streptococcal toxic 
shock syndrome in a postpartum woman. Case report and review of the 
literature. Infection. 1996;24:164–7.
 23. Mattingly PC, Mowat AG. Streptococcal pyomyositis following a sore 
throat. Rheumatol Rehabil. 1981;20:151–2.
 24. Unger MJ, Van Winkle GN, Ness-Wenum S. Pyomyositis secondary to 
group A beta hemolytic streptococcus. Wis Med J. 1991;90:465–7.
 25. Doebbeling BN, Wenzel RP. Spontaneous streptococcal gangrenous 
myositis: survival with early debridement. South Med J. 1989;82:900–2.
 26. Collier S, Vig N, Collier J. Two cases of tropical pyomyositis of the ster-
nocleidomastoid muscle occurring in the UK. Br J Oral Maxillofac Surg. 
2010;48:216–7.
 27. Martinez-Balzano C, Frechette V. Bacterial pyomyositis in a patient with sickle 
cell trait and pityriasis amiantacea. QJM. 2014;107:1035–7.
 28. Crum NF. Bacterial pyomyositis in the United States. Am J Med. 
2004;117:420–8.
 29. Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett’s principles 
and practice of infectious diseases. 8th ed. Philadelphia: Elsevier; 2014. p. 
2285–99.
 30. Hossain A, Reis ED, Soundararajan K, Kerstein MD, Hollier LH. Nontropi-
cal pyomyositis: analysis of eight patients in an urban center. Am Surg. 
2000;66:1064–6.
